Arcus Biosciences Company
Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.
Investors
%20.jpg)
Total Funding:
$226.7M
Investor Type:
N/A
Technology:
Anti-infective Drugs
Investment Stage:
N/A
Last Funding Type:
Series C
Estimated Revenue:
$1M to $10M
Founded Date:
2015
Industry:
PharmTech
Employee Number:
101-250
Funding Status:
IPO
Number Of Exists:
N/A
Headquarters:
Hayward, California, United States
Investors Number:
17